Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.

Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.

The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevated in pregnant women before the clinical onset of preeclampsia, but its predictive value in women with suspected preeclampsia is unclear.We performed a prospective, multicenter, observational study to...

Descrición completa

Detalles Bibliográficos
Main Authors:	Zeisler, H, Llurba, E, Chantraine, F, Vatish, M, Staff, A, Sennström, M, Olovsson, M, Brennecke, S, Stepan, H, Allegranza, D, Dilba, P, Schoedl, M, Hund, M, Verlohren, S
Formato:	Journal article
Idioma:	English
Publicado:	2016

Títulos similares

Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice.
por: Stepan, H, et al.
Publicado: (2015)

Implementation of the sFlt‐1/PlGF ratio for prediction and diagnosis of pre‐eclampsia in singleton pregnancy: implications for clinical practice
por: Stepan, H, et al.
Publicado: (2015)

sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics
por: Viktorija Tarasevičienė, et al.
Publicado: (2016-01-01)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
por: Ioakeim Sapantzoglou, et al.
Publicado: (2023-06-01)

Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis
por: Anca-Florina Tataru-Copos, et al.
Publicado: (2022-09-01)

Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia
por: Zeisler, H, et al.
Publicado: (2016)

Performance of sFlt-1/PlGF ratio ≥85 for ruling in preeclampsia within 4 weeks
por: Cerdeira, AS, et al.
Publicado: (2020)

Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia
por: Laura Ehrlich, et al.
Publicado: (2017-04-01)

Reduced expression in preterm birth of sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular vesicles suggests a potential biomarker
por: Sama Hussein, et al.
Publicado: (2022-12-01)

Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting
por: Zeisler, H, et al.
Publicado: (2019)

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
por: Dietmar Schlembach, et al.
Publicado: (2018-08-01)

Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia.
por: Evelyn Klein, et al.
Publicado: (2016-01-01)

Angiogenic factors (sFlt-1, PlGF) in twin pregnancy with placentaassociated complications
por: M. A. Kurtser, et al.
Publicado: (2022-11-01)

Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
por: Anna Maria Nuzzo, et al.
Publicado: (2021-01-01)

sFlt-1/PlGF ratio for prediction of preeclampsia in clinical routine: A pragmatic real-world analysis of healthcare resource utilisation
por: Anne Dathan-Stumpf, et al.
Publicado: (2022-01-01)

The sFlt-1/PlGF ratio as a predictor for poor pregnancy and neonatal outcomes
por: Yu-Shan Chang, et al.
Publicado: (2017-12-01)

The sFlt1/PlGF ratio predicts faster fetal deterioration in early fetal growth restriction: a historical cohort study
por: Palma Dos Reis, CR, et al.
Publicado: (2023)

The role of sFlt1/PlGF ratio in the assessment of preeclampsia and pregnancy-related hypertensive disorders
por: Jonathan Baert, et al.
Publicado: (2021-07-01)

sFlt-1, Not PlGF, Is Related to Twin Gestation Choronicity in the First and Third Trimesters of Pregnancy
por: Szymon Kozłowski, et al.
Publicado: (2021-06-01)

The Impact of Increased Maternal sFlt-1/PlGF Ratio on Motor Outcome of Preterm Infants
por: Lisa Middendorf, et al.
Publicado: (2022-06-01)

Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies
por: Alice Hoeller, et al.
Publicado: (2017-04-01)

Predictive value of the sFlt-1/PlGF ratio for preeclampsia in twin pregnancies: a retrospective study
por: Satoshi Shinohara, et al.
Publicado: (2021-10-01)

Аналіз перинатальних наслідків у жінок із високим і критичним рівнем співвідношення sFlt-1/PlGF
por: Yu.M. Duka, et al.
Publicado: (2023-03-01)

Multicentre randomised trial of screening with sFlt1/PlGF and planned delivery to prevent pre-eclampsia at term: protocol of the PE37 study
por: M Timmermans, et al.
Publicado: (2024-03-01)

The sflt-1/plgf ratio test in pre-eclampsia: an economic assessment for the UK
por: Vatish, M, et al.
Publicado: (2016)

Relationship between the sFlt-1/PlGF ratio and the optical coherence tomographic features of chorioretina in patients with preeclampsia.
por: Jaekyoung Lee, et al.
Publicado: (2021-01-01)

Перспективи використання sFlt-1, PlGF як біомаркерів прееклампсії, що приєдналася до хронічної гіпертензії
por: O.K. Popel, et al.
Publicado: (2022-11-01)

The sFlt-1/PlGF Ratio Trend Is Useful in Predicting Preeclampsia Severity in Hyperreactio Luteinalis Complicated with Preeclampsia
por: Risa Miyatake, et al.
Publicado: (2023-01-01)

sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates
por: Jacek Witwicki, et al.
Publicado: (2021-08-01)

The sFlt-1/PlGF Ratio in Patients Affected by Gestational Diabetes and SARS-CoV-2 Infection
por: Daniela Denis Di Martino, et al.
Publicado: (2022-12-01)

Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian populationAJOG Global Reports at a Glance
por: Namrata Kumar, MD, MRCOG, EFOG, FACOG, et al.
Publicado: (2023-05-01)

Correlation between uterine artery Doppler and the sFlt-1/PlGF ratio in different phenotypes of placental dysfunction
por: Vesna Fabjan-Vodusek, et al.
Publicado: (2019-01-01)

A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia
por: Vivek Pant, et al.
Publicado: (2019-07-01)

sFlt1/PlGF among patients with suspected preeclampsia when considering hypertensive statusAJOG Global Reports at a Glance
por: Easha Patel, MD, et al.
Publicado: (2024-08-01)

Would the utilization of sFlt-1/PlGF ratio in clinical practice prevent unnecessary hospital admissions of cases with preeclampsia?
por: Majed Alhudhud, et al.
Publicado: (2024-12-01)

The Angiogenic Markers PlGF and sFlt-1 in Cytomegalovirus Infection During Pregnancy: Insights from a Clinical Case
por: Valentina Giardini, et al.
Publicado: (2025-02-01)

Associations between Maternal sFlt-1/PlGF Ratio and Perinatal and Neonatal Outcomes in Newborns Born to Mothers with Preeclampsia
por: Hyo Ju Yang, et al.
Publicado: (2023-08-01)

Maternal PlGF and sFlt-1 are associated with low-birth-weight and/or small–for-gestational-age neonates in pregnancy with or without preeclampsia
por: Wenbo Luo, et al.

Soluble endoglin versus sFlt-1/PlGF ratio: detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohort
por: A. Iannaccone, et al.
Publicado: (2022-10-01)

Differentiating Maternal Angiogenesis Factors between Early and Late Onset Preeclampsia: Higher sflt-1 in Early Onset Preeclampsia, Lower PlGF and Higher sflt-1/PlGF Ratio in Late Onset Preeclampsia
por: Joserizal Serudji, et al.
Publicado: (2024-11-01)